Connect with our researchers, identify collaborators, discover their work
Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report Journal Article
Local Library Link: Find It @ Loyola
| Authors: | Bansal, V. K.; Herzog, C. A.; Sarnak, M. J.; Choi, M. J.; Mehta, R.; Jaar, B. G.; Rocco, M. V.; Kramer, H |
| Article Title: | Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report |
| Abstract: | Stroke risk may be more than 3-fold higher among patients with chronic kidney disease stage 5D (CKD-5D) compared to the general population, with the highest stroke rates noted among those 85 years and older. Atrial fibrillation (AF), a strong risk factor for stroke, is the most common arrhythmia and affects gt;7% of the population with CKD-5D. Warfarin use is widely acknowledged as an important intervention for stroke prevention with nonvalvular AF in the general population. However, use of oral anticoagulants for stroke prevention in patients with CKD-5D and nonvalvular AF continues to be debated by the nephrology community. In this National Kidney Foundation-Kidney Disease Outcomes Quality Initiative (NKF-KDOQI) controversies report, we discuss the existing observational studies that examine warfarin use and associated stroke and bleeding risks in adults with CKD-5D and AF. Non-vitamin K-dependent oral anticoagulants and their potential use for stroke prevention in patients with CKD-5D and nonvalvular AF are also discussed. Data from randomized clinical trials are urgently needed to determine the benefits and risks of oral anticoagulant use for stroke prevention in the setting of AF among patients with CKD-5D. |
| Journal Title: | American Journal of Kidney Diseases : The Official Journal of the National Kidney Foundation |
| Volume: | 70 |
| Issue: | 6 |
| ISSN: | 1523-6838; 0272-6386 |
| Publisher: | Elsevier Inc |
| Journal Place: | United States |
| Date Published: | 2017 |
| Start Page: | 859 |
| End Page: | 868 |
| Language: | eng |
| DOI/URL: |
S0272-6386(17)30888-0 |
| Notes: | LR: 20171205; CI: Copyright (c) 2017; JID: 8110075; 0 (Anticoagulants); 0 (Pyrazoles); 0 (Pyridines); 0 (Pyridones); 0 (Thiazoles); 3Z9Y7UWC1J (apixaban); 5Q7ZVV76EI (Warfarin); 9NDF7JZ4M3 (Rivaroxaban); I0VM4M70GC (Dabigatran); NDU3J18APO (edoxaban); OTO: NOTNLM; 2017/01/03 00:00 [received]; 2017/08/08 00:00 [accepted]; 2017/09/25 06:00 [pubmed]; 2017/12/06 06:00 [medline]; 2017/09/25 06:00 [entrez]; ppublish |
